347 related articles for article (PubMed ID: 8795569)
1. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
Berg K; Anholt H; Bech O; Moan J
Br J Cancer; 1996 Sep; 74(5):688-97. PubMed ID: 8795569
[TBL] [Abstract][Full Text] [Related]
2. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
Gaullier JM; Berg K; Peng Q; Anholt H; Selbo PK; Ma LW; Moan J
Cancer Res; 1997 Apr; 57(8):1481-6. PubMed ID: 9108449
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle.
Moan J; Bech O; Gaullier JM; Stokke T; Steen HB; Ma LW; Berg K
Int J Cancer; 1998 Jan; 75(1):134-9. PubMed ID: 9426701
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on the enhancement efficacy of specific and non-specific iron chelators for protoporphyrin IX production and photosensitization in HaCat cells.
Xia Y; Huang Y; Lin L; Liu X; Jiang S; Xiong L
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):765-70. PubMed ID: 20037824
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.
Iinuma S; Farshi SS; Ortel B; Hasan T
Br J Cancer; 1994 Jul; 70(1):21-8. PubMed ID: 8018536
[TBL] [Abstract][Full Text] [Related]
7. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors.
Curnow A; Pye A
J Environ Pathol Toxicol Oncol; 2007; 26(2):89-103. PubMed ID: 17725535
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
Chang SC; MacRobert AJ; Porter JB; Bown SG
J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
Pye A; Curnow A
Photochem Photobiol; 2007; 83(3):766-73. PubMed ID: 17576385
[TBL] [Abstract][Full Text] [Related]
10. The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid.
Bech O; Berg K; Moan J
Cancer Lett; 1997 Feb; 113(1-2):25-9. PubMed ID: 9065797
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.
Noodt BB; Berg K; Stokke T; Peng Q; Nesland JM
Br J Cancer; 1996 Jul; 74(1):22-9. PubMed ID: 8679453
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
16. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
17. Photodynamically induced effects in colon carcinoma cells (WiDr) by endogenous photosensitizers generated by incubation with 5-aminolaevulinic acid.
Gederaas OA; Rasch MH; Berg K; Lagerberg JW; Dubbelman TM
J Photochem Photobiol B; 1999 Apr; 49(2-3):162-70. PubMed ID: 10392465
[TBL] [Abstract][Full Text] [Related]
18. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
20. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
